Impact of HPV vaccination with Gardasil® in Switzerland

Impact of HPV vaccination with Gardasil® in Switzerland

Abstract Background Gardasil®, a quadrivalent vaccine targeting low-risk (6, 11) and high-risk (16, 18) human papillomaviruses (HPV), has been offered to 11–14 year-old schoolgirls in Switzerland since 2008. To evaluate its success and its potential impact on cervical cancer screening, HPV genotypes...

Full description

Bibliographic Details
Main Authors: Martine Jacot-Guillarmod, Jérôme Pasquier, Gilbert Greub, Massimo Bongiovanni, Chahin Achtari, Roland Sahli
Format: Article
Language:English
Published: BMC 2017-12-01
Series:BMC Infectious Diseases
Subjects:
Human papillomavirus
HPV genotyping
HPV vaccine
Gardasil®
Chlamydia trachomatis
Real-time PCR
Online Access:http://link.springer.com/article/10.1186/s12879-017-2867-x

Internet

http://link.springer.com/article/10.1186/s12879-017-2867-x

Similar Items